Decision Financial Statements From 2010 to 2026

DECN Stock  USD 0.0001  0.00  0.00%   
Decision Diagnostics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Decision Diagnostics' valuation are provided below:
Gross Profit
462.2 K
Market Capitalization
35.8 K
Enterprise Value Revenue
1.4379
Revenue
2.1 M
Earnings Share
(0.02)
We have found one hundred twenty available fundamental signals for Decision Diagnostics, which can be analyzed and compared to other ratios and to its rivals. Self-guided Investors are advised to verify Decision Diagnostics' prevailing fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. As of the 4th of January 2026, Market Cap is likely to drop to about 3.3 M. In addition to that, Enterprise Value is likely to drop to about 3.9 M

Decision Diagnostics Total Revenue

1.69 Million

Check Decision Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Decision Diagnostics' main balance sheet or income statement drivers, such as Interest Expense of 32.9 M, Selling General Administrative of 2.6 M or Total Revenue of 1.7 M, as well as many indicators such as Price To Sales Ratio of 2.65, Dividend Yield of 0.068 or PTB Ratio of 7.9. Decision financial statements analysis is a perfect complement when working with Decision Diagnostics Valuation or Volatility modules.
  
Build AI portfolio with Decision Stock
Check out the analysis of Decision Diagnostics Correlation against competitors.
To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.

Decision Diagnostics Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets5.2 M6.5 MM
Slightly volatile
Other Current Liabilities222.7 K276 K201.2 K
Slightly volatile
Total Current Liabilities3.5 M5.7 M3.8 M
Slightly volatile
Total Stockholder Equity413.5 K435.2 K776.3 K
Slightly volatile
Other Liabilities321.1 K281.8 K284.4 K
Very volatile
Accounts Payable2.1 MM1.1 M
Slightly volatile
Cash637.2 K600.7 K660.6 K
Very volatile
Other Assets16.8 K18.9 K20.6 K
Slightly volatile
Net Receivables1.2 M849.4 K1.1 M
Slightly volatile
Other Current Assets1.4 M988.3 K1.1 M
Slightly volatile
Total Liabilities3.9 M5.9 M4.2 M
Slightly volatile
Deferred Long Term Liabilities17 K19.1 K20.9 K
Slightly volatile
Short and Long Term Debt1.9 M3.4 M2.2 M
Slightly volatile
Preferred Stock Total Equity800900982
Slightly volatile
Total Current Assets2.5 M1.5 M2.6 M
Slightly volatile
Short Term Debt1.6 M2.3 M1.8 M
Slightly volatile
Common Stock428.1 K407.7 K196.8 K
Slightly volatile
Intangible Assets3.9 M3.7 M1.9 M
Slightly volatile
Long Term Debt632.7 K549.3 K714.2 K
Slightly volatile
Inventory219.8 K184.8 K165.5 K
Slightly volatile
Property Plant Equipment771.4 K922.7 K612.7 K
Slightly volatile
Property Plant And Equipment Net641.9 K722.1 K788.2 K
Slightly volatile
Net DebtM2.2 M2.5 M
Slightly volatile
Non Current Assets Total4.4 M4.6 M4.1 M
Slightly volatile
Non Currrent Assets Other779.6 K843.9 K713.4 K
Slightly volatile
Common Stock Shares Outstanding284 M409.9 M239.8 M
Slightly volatile
Non Current Liabilities Total196.1 K220.6 K240.7 K
Slightly volatile
Net Invested Capital3.5 M3.9 M3.1 M
Slightly volatile
Property Plant And Equipment Gross641.9 K722.1 K788.2 K
Slightly volatile
Capital Stock285.1 K410.2 K240.9 K
Slightly volatile

Decision Diagnostics Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative2.6 M2.7 M2.4 M
Very volatile
Total Revenue1.7 M1.8 M3.5 M
Slightly volatile
Gross Profit774.8 K448.6 K728.7 K
Slightly volatile
Cost Of Revenue1.3 M1.3 M2.8 M
Slightly volatile

Decision Diagnostics Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Sale Purchase Of Stock750.6 K488.8 K561.5 K
Very volatile
Total Cash From Financing Activities2.5 M2.4 M1.5 M
Slightly volatile
Depreciation600 K675 K736.8 K
Slightly volatile
Stock Based Compensation20 K22.5 K24.6 K
Slightly volatile
Change In Working Capital544.6 K573.2 K1.8 M
Slightly volatile
Other Non Cash Items32.2 M30.7 M11.8 M
Slightly volatile
Issuance Of Capital Stock240 K270 K294.7 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.652.795.4267
Slightly volatile
Dividend Yield0.0680.07650.0835
Slightly volatile
PTB Ratio7.98.9317.9432
Slightly volatile
Days Sales Outstanding185200167
Slightly volatile
Book Value Per Share0.0020.00210.7186
Slightly volatile
Average Payables1.4 M1.3 MM
Slightly volatile
Stock Based Compensation To Revenue0.01150.01210.0197
Pretty Stable
Capex To Depreciation0.04250.04770.0521
Slightly volatile
PB Ratio7.98.9317.9432
Slightly volatile
EV To Sales3.984.187.8957
Slightly volatile
Inventory Turnover10.0710.611.7654
Slightly volatile
Days Of Inventory On Hand53.0935.6573.7806
Slightly volatile
Payables Turnover0.951.010.5697
Slightly volatile
Sales General And Administrative To Revenue1.361.052.6022
Slightly volatile
Average Inventory182.6 K147.3 K191.8 K
Pretty Stable
Capex To Revenue0.00.00.4613
Slightly volatile
Cash Per Share0.00210.00230.0892
Slightly volatile
Days Payables Outstanding231378412
Very volatile
Intangibles To Total Assets0.40.660.4367
Pretty Stable
Current Ratio0.280.30.7363
Slightly volatile
Receivables Turnover2.292.412.532
Slightly volatile
Shareholders Equity Per Share0.0020.00210.7186
Slightly volatile
Debt To Equity3.065.447.6771
Very volatile
Average Receivables1.7 M1.1 M1.1 M
Very volatile
Revenue Per Share0.00810.00853.07
Slightly volatile
Interest Debt Per Share0.120.134.1373
Slightly volatile
Debt To Assets1.060.60.5632
Very volatile
Graham Number1.251.41.5298
Slightly volatile
Operating Cycle224246226
Pretty Stable
Price Book Value Ratio7.98.9317.9432
Slightly volatile
Days Of Payables Outstanding231378412
Very volatile
Ebt Per Ebit13.2812.656.4834
Slightly volatile
Company Equity Multiplier5.6810.5213.2137
Very volatile
Long Term Debt To Capitalization0.560.790.8346
Pretty Stable
Total Debt To Capitalization0.940.990.794
Slightly volatile
Debt Equity Ratio3.065.447.6771
Very volatile
Quick Ratio0.250.270.6998
Slightly volatile
Net Income Per E B T0.60.91.0439
Slightly volatile
Cash Ratio0.220.120.2
Pretty Stable
Days Of Inventory Outstanding53.0935.6573.7806
Slightly volatile
Days Of Sales Outstanding185200167
Slightly volatile
Price To Book Ratio7.98.9317.9432
Slightly volatile
Fixed Asset Turnover2.692.846.7838
Slightly volatile
Debt Ratio1.060.60.5632
Very volatile
Price Sales Ratio2.652.795.4267
Slightly volatile
Asset Turnover0.380.40.5312
Slightly volatile
Price Fair Value7.98.9317.9432
Slightly volatile

Decision Diagnostics Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap3.3 M4.3 M4.8 M
Very volatile
Enterprise Value3.9 M6.5 M5.9 M
Slightly volatile

About Decision Diagnostics Financial Statements

Decision Diagnostics investors utilize fundamental indicators, such as revenue or net income, to predict how Decision Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Total Revenue1.8 M1.7 M
Cost Of Revenue1.3 M1.3 M
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 1.05  1.36 
Revenue Per Share 0.01  0.01 
Ebit Per Revenue(0.96)(1.01)

Pair Trading with Decision Diagnostics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Decision Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Decision Diagnostics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Decision Stock

  1.0NHEL Natural Health FarmPairCorr
The ability to find closely correlated positions to Decision Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Decision Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Decision Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Decision Diagnostics to buy it.
The correlation of Decision Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Decision Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Decision Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Decision Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Decision Diagnostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Decision Diagnostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Decision Diagnostics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Decision Diagnostics Stock:
Check out the analysis of Decision Diagnostics Correlation against competitors.
To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Decision Diagnostics. If investors know Decision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Decision Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.02)
Revenue Per Share
0.006
Quarterly Revenue Growth
(0)
Return On Assets
(0.21)
Return On Equity
(81.61)
The market value of Decision Diagnostics is measured differently than its book value, which is the value of Decision that is recorded on the company's balance sheet. Investors also form their own opinion of Decision Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Decision Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Decision Diagnostics' market value can be influenced by many factors that don't directly affect Decision Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Decision Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Decision Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Decision Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.